Peptic Ulcer Disease
📧 Sign up to get email alerts when something new happens for Peptic Ulcer Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2008-06-30FDA Approved: ACIPHEX — Supplemental Application (Waylis Therapeutics LLC)
The FDA approved a supplemental application for ACIPHEX (rabeprazole sodium) submitted by Waylis Therapeutics LLC.
-
FDA approval · 2008-03-20FDA Approved: RANITIDINE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for ranitidine from Amneal Pharmaceuticals of New York LLC, authorizing the continued marketing of a…
-
FDA approval · 2008-02-27FDA Approved: FAMOTIDINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for famotidine from Teva Pharmaceuticals USA, Inc., updating the approved generic product.
-
FDA approval · 2007-12-21FDA Approved: OMEPRAZOLE AND SODIUM BICARBONATE — Supplemental Application (Oceanside Pharmaceuticals)
FDA approved a supplemental application for the combination product omeprazole and sodium bicarbonate from Oceanside Pharmaceuticals.
-
FDA approval · 2007-12-20FDA Approved: PROTONIX DELAYED-RELEASE — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
The FDA approved a supplemental application for PROTONIX DELAYED-RELEASE (pantoprazole sodium) from Wyeth Pharmaceuticals LLC, a subsidiary …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2007-08-31FDA Approved: RANITIDINE — Original Application (Dr. Reddy's Laboratories Limited)
FDA approved the original ANDA for ranitidine from Dr. Reddy's Laboratories Limited, enabling a generic ranitidine product to be marketed in…
-
FDA approval · 2007-08-20FDA Approved: CLARITHROMYCIN — Original Application (Chartwell RX, LLC.)
FDA approved a generic version of clarithromycin from Chartwell RX, LLC through an Original Abbreviated New Drug Application (ANDA).
-
FDA approval · 2007-04-26FDA Approved: CARAFATE — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for CARAFATE (sucralfate) from Allergan, Inc., resulting in updated labeling and/or indication infor…
-
FDA approval · 2006-10-13FDA Approved: RANITIDINE — Original Application (Amneal Pharmaceuticals of New York LLC)
The FDA approved Amneal Pharmaceuticals of New York LLC's original application for generic ranitidine, authorizing its commercial ranitidine…
-
FDA approval · 2006-09-25FDA Approved: FAMOTIDINE — Original Application (Chain Drug Consortium, LLC)
The FDA approved Chain Drug Consortium, LLC's original application for famotidine, enabling a generic version of famotidine to be marketed. …
-
FDA approval · 2006-07-25FDA Approved: PROTONIX DELAYED-RELEASE — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
The FDA approved a supplemental application for Protonix Delayed-Release (pantoprazole sodium) submitted by Wyeth Pharmaceuticals LLC, a sub…